Prostatype Genomics
Prostatype Genomics CFO Michael af Winklerfelt is leaving the company - recruitment process for the position has begun
REG
"We are very grateful for all the work that Michael has carried out during his three years at Prostatype Genomics, in the management team and in close cooperation with the board. In everything from the group's financial management and financial strategy, to efforts in the transformation from a research and development activity to a commercially focused company and the internationalization of Prostatype Genomics. I want to thank Michael for his commitment, good efforts and a nice camaraderie during his time in Prostatype Genomics, and wish him all the best in the future", says Fredrik Persson, CEO of Prostatype Genomics.
| Datum | 2023-09-04, kl 18:06 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!